Search: WFRF:(Søreide Kjetil)
> (2021) >
The liver-first app...
-
Zeyara, AdamLund University,Lunds universitet,Kirurgi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Surgery (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Ystad Hospital
(author)
The liver-first approach for synchronous colorectal liver metastases: A systematic review and meta-analysis of completion rates and effects on survival
- Article/chapterEnglish2021
Publisher, publication year, extent ...
-
2021-10-03
-
SAGE Publications,2021
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:0a69d701-9393-4d78-a737-88a3d5f7270d
-
https://lup.lub.lu.se/record/0a69d701-9393-4d78-a737-88a3d5f7270dURI
-
https://doi.org/10.1177/14574969211030131DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:for swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
Background: Patients presenting with synchronous colorectal liver metastases are increasinglybeing considered for a curative treatment, and the liver-first approach is gaining popularity in thiscontext. However, little is known about the completion rates of the liver-first approach and itseffects on survival.Methods:A systematic review and meta-analysis of liver-first strategy for colorectal liver metastasis.The primary outcome was an assessment of the completion rates of the liver-first approach.Secondary outcomes included overall survival, causes of non-completion, and clinicopathologicdata.Results: Seventeen articles were amenable for inclusion and the total study population was 1041.The median completion rate for the total population was 80% (range 20–100). The median overallsurvival for the completion and non-completion groups was 45 (range 12–69) months and 13 (range10.5–25) months, respectively. Metadata showed a significant survival benefit for the completiongroup, with a univariate hazard ratio of 12.0 (95% confidence interval, range 5.7–24.4). The majorcause of non-completion (76%) was liver disease progression before resection of the primarytumor. Pearson tests showed significant negative correlation between median number of lesionsand median size of the largest metastasis and completion rate.Conclusions: The liver-first approach offers a complete resection to most patients enrolled, withan overall survival benefit when completion can be assured. One-fifth fails to return to intendedoncologic therapy and the major cause is interim metastatic progression, most often in the liver.Risk of non-completion is related to a higher number of lesions and large metastases. The majorityof studies stem from primary
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Torén, WilliamLund University,Lunds universitet,Lever-, pankreas- och gallvägskirurgi,Forskargrupper vid Lunds universitet,Hepato-Pancreato-Biliary Surgery,Lund University Research Groups(Swepub:lu)wi0485to
(author)
-
Søreide, KjetilStavanger University Hospital,University of Bergen
(author)
-
Andersson, RolandLund University,Lunds universitet,Lever-, pankreas- och gallvägskirurgi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Hepato-Pancreato-Biliary Surgery,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments(Swepub:lu)kir-ran
(author)
-
Kirurgi, LundSektion V
(creator_code:org_t)
Related titles
-
In:Scandinavian Journal of Surgery: SAGE Publications1799-72671457-4969
Internet link
Find in a library
To the university's database